Fibromyalgia & musculoskeletal pain
Validation of Qualisex questionnaire to evaluate sexual dysfunction in women affected by fibromyalgia
Authors' conclusion
This study validated Qualisex questionnaire as a good test for the sexual disorders' evaluation in FM women.
Study context
- Population
- Women with fibromyalgia (FM) (ACR 2016) referred to a Fibromyalgia Clinic, 2020 to 2022
- Participants
- 373 women
- Outcome
- Internal consistency of the Qualisex questionnaire (Cronbach's alpha)
Methodological detailsconsecutive enrolment, single-centre
- Consecutive enrolment
- Single-centre
Performance
As reported in the abstract
Qualisex validation (internal consistency)
Cronbach's alpha
0.878
Further findings
Factors associated with higher Qualisex values
- Higher in married women
- P < 0.001
- Higher with lower grade of education
- P = 0.002
- Higher with lower sexual feeling with partner
- P < 0.001
Correlations with Qualisex Total score
- HADS-A
- P < 0.001 r=0.312
- HADS-D
- P < 0.001 r=0.542
- VAS pain
- P < 0.001 r=0,438
- VAS fatigue
- P < 0.001 r=0.375
- VAS dryness
- P < 0.001 r=0.370
- Relationship duration
- P < 0.001 r=0.202
- Positive correlation
Multivariate analysis of Qualisex Total score, corrected for age
- Significant influence of relationship duration, VAS pain, fatigue, dryness, HADS-A/D, Revised Fibromyalgia Impact Questionnaire (R-FIQ) and all Qualisex items
- P < 0.001
Original publication
Validation of Qualisex questionnaire to evaluate sexual dysfunction in women affected by fibromyalgia. Clin Exp Rheumatol. Published 12 June 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →